TREANDA
NDC 63459-391, Bendamustine Hydrochloride, injection, powder, lyophilized, for solution, from Cephalon, LLC.
- Product NDC
- 63459-391
- Status
- Listed
- Labeler
- Cephalon, LLC
- Dosage form
- INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION
- Route
- INTRAVENOUS
- Product type
- HUMAN PRESCRIPTION DRUG
- Marketing category
- NDA
- Application
- NDA022249
- DEA schedule
- None
curl https://api.healthcare.dev/v1/drugs/ndc/63459-391 \ -H "Authorization: Bearer $HDEV_API_KEY"
Product
Active ingredients and packages
Active ingredients
- BENDAMUSTINE HYDROCHLORIDE100 mg/20mL
Pharmacologic classes
Alkylating Activity [MoA]; Alkylating Drug [EPC]
| Package NDC | NDC-11 | Package |
|---|---|---|
| 63459-391-20 | 63459039120 | 1 VIAL, SINGLE-DOSE in 1 CARTON (63459-391-20) / 20 mL in 1 VIAL, SINGLE-DOSE |
Linked data
RxNorm, label and prices
Related lookups
FDA label sections
GET /v1/drugs/labels/39d53698-57fa-7c99-fc5b-f52a55684826Medicare Part B payment limits (ASP)
GET /v1/drugs/asp?ndc=63459-391
Use it
Look up 63459-391 from code or an agent
curl https://api.healthcare.dev/v1/drugs/ndc/63459-391 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up NDC 63459-391. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.